Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Annually, our Advisors make a personal financial contribution to cover LSC’s administrative costs, allowing us to channel money raised from our event fundraisers, Corporate Membership Program, and from individuals to our partner organizations.
Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.
PHILADELPHIA BOARD OF ADVISORS
Tom Anderson
CEO – SwanBio TherapeuticsArmando Anido
Chairman & CEO – Zynerba PharmaceuticalsScott Applebaum
SVP & Chief Legal and Compliance Officer – TrevenaUsman "Oz" Azam
President & CEO – TmunityLou Beardell
Partner – Morgan Lewis & BockiusKelly Beck
CEO – PolyCore TherapeuticsCarrie Bourdow
President & CEO – TrevenaDerek Bowen
Vice President – BlackfynnScott Braunstein
CEO – Marinus TherapeuticsClifford Brechner
Vice President – ColliersChristopher Burns
President & CEO – VenatorxRachael Bushey
Partner – Troutman PepperRon Cariola
International Director – JLLBarb Carlin
Managing Director - MidAtlantic – Danforth AdvisorsBrett Ciarelli
Sr. Vice President – Morgan Stanley Private Wealth ManagementJohn Crowley
Chairman and CEO – Amicus TherapeuticsLisa Dalton
Chief People Officer – Spark TherapeuticsJeff Dayno
Chief Medical Officer – Harmony BiosciencesPhillip Duffy
Korn Ferry
Phillip Duffy
Korn FerryJohn Fry
President – Drexel UniversitySteven Gelone
President & COO – Nabriva TherapeuticsJohn Gerard
Retired Partner – KPMGMaxine Gowen
CEO – Tamuro BioJohn Grady
Sr. VP Development – Wexford Science + TechnologyDaniel Hayes
Principal, Life Sciences – CliftonLarsonAllen LLPThomas Hess
CFO – GenomindStephen Hurly
CEO – LAVA TherapeuticsJohn Jacobs
Chairman and CEO – Harmony BiosciencesSteve Jannetta
Partner – Morgan Lewis & BockiusSteven Kelly
President & CEO – Carisma TherapeuticsMartin Lehr
CEO – Context TherapeuticsJeff Libson
Partner – CooleyEvan Loh
CEO – Paratek PharmaceuticalsKevin Mahoney
CEO – University of Pennsylvania Health SystemFrancesco Maria Lavino
CEO – F2G LtdJean Marie Markham
Founder & CEO – ClinlogixJohn Maslowski
CEO – Castle Creek Biosciences, Inc.Steven Nichtberger
CEO, President & Chairman – Cabaletta BioShawn Patrick O'Brien
CEO – GenomindBruce Peacock
Biopharmaceutical executive and board member
Bruce Peacock
Biopharmaceutical executive and board memberMatthew Pearson
Partner – Akin GumpMike Pellini
Managing Partner – Section 32Jill Quigley
Chief Operating Officer – Passage BioRobert Radie
CEO & Chairman – Neuraptive TherapeuticsMaryellen Royle
Partner – EvokeKYNERob Sarisky
Biopharmaceutical executive and board member
Rob Sarisky
Biopharmaceutical executive and board memberKathleen Shay
Partner – Duane MorrisBruce Shook
CEO – Vesper MedicalSteve Simpson
Partner – EYJudith Steenbergen
President – SMAC LLCDan Strauss
Partner – Klein Hersh InternationalJoseph Truitt
Biopharmaceutical executive and board member
Joseph Truitt
Biopharmaceutical executive and board memberEvan Tzanis
Executive Vice President – Neuraptive TherapeuticsTyler Vandegrift
Managing Director – JLLStephen Webster
Biopharmaceutical executive and board member
Stephen Webster
Biopharmaceutical executive and board member